STOCK TITAN
  1. Home
  2. Sec-filings
  3. OSCR
  4. [Form 4] Oscar Health, Inc. Insider Trading Activity

Oscar Health (OSCR) officer sells 7,338 shares to cover tax withholding

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Oscar Health, Inc. reported an insider stock sale by a senior officer. On 12/02/2025, the President of Oscar Insurance sold 7,338 shares of Class A common stock at a weighted average price of $16.59 per share. After this transaction, the reporting person beneficially owns 172,527 shares directly.

The sale was made under a pre-arranged Rule 10b5-1 trading instruction entered into on August 8, 2025 and was intended to cover the officer’s tax withholding obligations related to the vesting of previously granted equity awards. The shares were sold in multiple trades at prices ranging from $16.37 to $16.78.

Positive

  • None.

Negative

  • None.
Insider Liang Janet
Role President, Oscar Insurance
Sold 7,338 shs ($122K)
Type Security Shares Price Value
Sale Class A Common Stock 7,338 $16.59 $122K
Holdings After Transaction: Class A Common Stock — 172,527 shares (Direct)
Footnotes (1)
  1. The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.37 to $16.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Liang Janet
(Last) (First) (Middle)
75 VARICK STREET, 5TH FLOOR
(Street)
NEW YORK NY 10013
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Oscar Health, Inc. [ OSCR ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
President, Oscar Insurance
3. Date of Earliest Transaction (Month/Day/Year)
12/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 12/02/2025 S 7,338(1) D $16.59(2) 172,527 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.
2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.37 to $16.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Remarks:
/s/ Melissa Curtin, Attorney-in-fact 12/04/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Oscar Health (OSCR) disclose in this Form 4?

Oscar Health disclosed that the President of Oscar Insurance sold 7,338 shares of the company’s Class A common stock on 12/02/2025.

At what price were the Oscar Health (OSCR) shares sold in this insider trade?

The shares were sold at a weighted average price of $16.59, with individual trades executed between $16.37 and $16.78 per share.

Why did the Oscar Health (OSCR) officer sell 7,338 shares?

The sale was effected under a Rule 10b5-1 instruction letter and was intended to satisfy the reporting person’s tax withholding obligation upon vesting of earlier equity awards.

How many Oscar Health (OSCR) shares does the insider own after this transaction?

Following the reported sale, the officer beneficially owns 172,527 shares of Oscar Health Class A common stock in direct ownership.

Was the Oscar Health (OSCR) insider trade made under a 10b5-1 plan?

Yes. The filing states the sale was made pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025.

What type of security was involved in this Oscar Health (OSCR) Form 4 filing?

The transaction involved Class A common stock of Oscar Health, Inc. There were no derivative securities reported in the provided tables.